Study details 9-pathogen feline respiratory multiplex assay

A newly published study in the Journal of Veterinary Diagnostic Investigation reports a quantitative multiplex platform for detecting nine feline respiratory pathogens in one assay, combining RT-PCR/PCR with capillary electrophoresis. The platform is positioned as a more sensitive, cost-conscious alternative to narrower feline upper respiratory testing approaches, with the added aim of improving recognition of coinfections that can blur the clinical picture in cats with upper respiratory tract disease. (pmc.ncbi.nlm.nih.gov)

That matters because feline upper respiratory disease has long been diagnostically messy. Core respiratory panels typically focus on pathogens such as feline calicivirus, feline herpesvirus-1, Chlamydia felis, Bordetella bronchiseptica, Mycoplasma felis, and sometimes influenza A. But published literature shows that clinical signs often overlap, mixed infections are common, and test interpretation can be difficult when organisms are also present in apparently healthy or chronically infected cats. In shelter and multicat settings, where stress and close contact increase transmission pressure, those limitations become more consequential. (onlinelibrary.wiley.com)

According to the source abstract, the new assay broadens the diagnostic menu by including nine targets: feline calicivirus, felid alphaherpesvirus 1, Mycoplasmopsis felis, Chlamydia felis, Bordetella bronchiseptica, influenza A virus, feline reovirus, feline panleukopenia virus, and feline coronavirus. That expanded scope is notable because some recent feline respiratory multiplex assays in the literature have focused on six or seven pathogens, while other emerging platforms have paired multiplex PCR with portable analyzers or one-step qPCR formats. The new study’s pitch is that a combined RT-PCR/PCR and capillary electrophoresis workflow may improve sensitivity without the cost burden of running multiple separate assays. (pubmed.ncbi.nlm.nih.gov)

The broader backdrop supports the need for better multiplex tools. A 2024 study validating multiplex qPCR/RT-qPCR assays for feline respiratory disease complex reported high analytical performance and found Mycoplasma felis, feline herpesvirus-1, Chlamydia felis, and feline calicivirus among the most frequently detected pathogens in tested samples. Epidemiologic work from Australia and newer surveillance data from China likewise show that respiratory pathogen detection in cats is common, with coinfections and variable regional prevalence shaping the diagnostic landscape. (pubmed.ncbi.nlm.nih.gov)

Outside commentary on this specific paper appears limited so far, but the surrounding expert literature is consistent on a key point: more detection is not automatically better care unless clinicians can interpret the result in context. Reviews and guidelines note that PCR panels can be especially useful during outbreaks, in shelters, catteries, boarding facilities, and multicat homes, or when severe disease warrants a more targeted workup. At the same time, experts caution that positive results may reflect colonization, latent infection, or vaccine-related detection rather than the sole cause of disease. (onlinelibrary.wiley.com)

Why it matters: For veterinary professionals, this study speaks to two practical pressures at once: antimicrobial stewardship and diagnostic efficiency. If a single test can more reliably identify viral and bacterial contributors, or rule out expected pathogens, it may help reduce empiric treatment, support isolation decisions, and sharpen outbreak management. That could be particularly useful in feline practice, shelter medicine, and referral diagnostics, where clinicians often need answers fast and pet parents want clarity on prognosis, contagion risk, and household spread. Still, the real test will be whether the assay improves decision-making at the case level, not just analytical sensitivity on paper. (onlinelibrary.wiley.com)

There are also important caveats. Some targets on expanded panels may have uncertain clinical significance in a given patient, and sample site still affects yield. Earlier research found that combining sampling sites can improve detection, underscoring that assay performance is only one part of diagnostic accuracy. For clinicians, that means a broader panel should complement, not replace, case history, housing context, vaccination status, physical exam findings, and, when needed, culture or imaging. (pubmed.ncbi.nlm.nih.gov)

What to watch: The next milestones are likely to be full-text publication details on analytical performance, pathogen-by-pathogen limits of detection, and clinical validation in real-world feline cases. If outside labs replicate the findings, this kind of lower-cost multiplex platform could become more relevant for routine respiratory workups and outbreak investigations, particularly where current qPCR panels are too narrow or too expensive for broad use. (pubmed.ncbi.nlm.nih.gov)